BRTX - Rasio utang marang kapitalisasi buku biorestorative.com

BioRestorative Therapies (BRTX) is recognized as an innovator in spinal regeneration, developing non-surgical treatment methods. The debt-to-book capitalization trend clearly illustrates financial stability, where the value of 0.01 determines this level. The business relies on external financing due to regulatory risks, while the binary threats of a single-product pipeline are mitigated by the development of metabolic obesity therapy.

BRTX (BioRestorative Therapies, Inc.) riwayat Utang marang nilai buku saka 04.07.2022 nganti 28.10.2026

biorestorative.com (BRTX) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:

Rega saham BioRestorative Therapies, Inc.|BRTX - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar BRTX|BRTX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham BioRestorative Therapies|BRTX - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku biorestorative.com|BRTX - Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas BioRestorative Therapies|BRTX - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas BioRestorative Therapies, Inc.|BRTX - Utang perusahaan|Rasio utang marang kapitalisasi buku BRTX|BRTX - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan BioRestorative Therapies

Ringkesan analitik perusahaan:BioRestorative

Produk asli BioRestorative Therapies, Inc.

This ratio determines the proportion of debt within the company's overall equity structure. Investors assess credit risk by comparing debt growth rates with net asset dynamics. By analyzing the debt-to-capitalization financial stability metric, one can identify hidden solvency trends. For BioRestorative Therapies (BRTX), this is critical when financing costly ESG initiatives. Effective liability management ensures the ethical development of stem cell products and the environmental safety of laboratories.

Pesaing BioRestorative Therapies

MESO: Utang-utang marang kapitalisasi buku|lineagecell.com - Utang-utang marang nilai buku|SRZN: Rasio utang marang kapitalisasi buku|CCEL - Utang marang nilai buku|FBLG (fibrobiologics.com) - Utang-utang marang kapitalisasi buku|Longeveron Corporation (LGVN) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku CELZ (Creative Medical Technology Holdings, Inc.)